LifeTech Scientific Corporation
LFTSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 2.9% | 15.5% | 18.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 75.3% | 78.6% | 79.6% | 80.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 14.3% | 30.2% | 34.3% | 35.5% |
| Other Income/Exp. Net | $0 | -$0 | $0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 17.1% | 20.8% | 29.6% | 31.6% |
| EPS | 0.051 | 0.059 | 0.077 | 0.068 |
| % Growth | -13.6% | -23.4% | 13.2% | – |
| EPS Diluted | 0.051 | 0.059 | 0.074 | 0.064 |
| Weighted Avg Shares Out | 4 | 4 | 4 | 5 |
| Weighted Avg Shares Out Dil | 4 | 4 | 4 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 22.2% | 20% | 40.6% | 43% |